SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-356321
Filing Date
2018-12-21
Accepted
2018-12-21 16:07:14
Documents
5
Effectiveness Date
2018-12-21

Document Format Files

Seq Description Document Type Size
1 S-8 d670312ds8.htm S-8 39634
2 EX-5.1 d670312dex51.htm EX-5.1 6850
3 EX-23.1 d670312dex231.htm EX-23.1 1689
4 GRAPHIC g670312g55d43.jpg GRAPHIC 2615
5 GRAPHIC g670312g67v46.jpg GRAPHIC 3058
  Complete submission text file 0001193125-18-356321.txt   57289
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-228969 | Film No.: 181249583
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1